secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sharps Technology Inc. (STSS)
CIK:        0001737995
Form:       8-K
Filed at:   2024-07-25T23:59:59+00:00
Accession:  0001493152-24-029022
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Sharps Technology enters 5-year deal for 520M syringes, selling out EU facility capacity
--------------------------------------------------------------------------------

- 5-year supply agreement with Stericare Solutions for 520M units of 10mL SoloGard syringes.
- Expected revenue exceeds $50M; first delivery targeted November 2024.
- Agreement sells out current manufacturing capacity for 10mL SoloGard at EU facility.
- Customer is a U.S. supplier of medical saline/water products; evaluation triggered by FDA recalls and Chinese syringe tariffs.
- Q4 2024 revenue ramp begins; company to expand EU facility for future growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737995/000149315224029022/0001493152-24-029022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737995/000149315224029022/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-029022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer